Isomorphic Labs, a subsidiary of Alphabet Inc., is set to accelerate AI-driven drug discovery after it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co.
Novartis AG
Breaking News
Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.
Novartis AG said on Monday its drug Gilenya failed to meet its main goal in a late-stage study as a treatment for primary progressive multiple sclerosis (PPMS).
Australia's CSL Ltd (CSL.AX), the world's largest blood products company, said on Monday it had agreed to buy Novartis AG's (NOVN.VX) global influenza vaccine business for $275 million.
Basel-based Novartis AG sold its California blood unit to Spain's Grifol's SA for USD1.68 billion.
The Swiss Market Index climbed as Novartis advanced studies on multiple sclerosis while Roche releases arthritis drug.
In compliance with current regulations, Novartis AG is selling of a part of its shareholdings in Novartis India.
Subscribe to VCpost newsletter
Most Popular
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Convicted Fraudster Accused of Killing Wealthy Heiress Wife in Swimming Pool to Cash in on Over $4 Million Fortune
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
